Lanzatech co-founder: we are missing out on the synthetic biology revolution

Lanzatech co-founder: we are missing out on the synthetic biology revolution
Dr Sean Simpson. (Image: Getty)
Peter Griffin
The third New Zealand-founded company in as many years is set to list on the Nasdaq.LanzaTech’s merger with “blank cheque” Nasdaq-listed company AMCI Acquisition Corp II sees it follow in the footsteps of Rocket Lab and footwear maker All Birds in taking the special purpose acquisition company (SPAC) route to become a publicly traded company.The deal, which values the merged company at around US$1.8 billion (NZ$2.8b), was cleared by shareholders on Tuesday. It confirms the Illinois-based LanzaTech’s status as our mo...

More Opinion

A roadmap for global investment
Opinion

Simon Robertson: A roadmap for global investment

The drawdowns and the snapbacks in the markets have been brutal.

Simon Robertson 07 Jun 2025
Turf war: Sheep vs forestry
Opinion

Richard Holloway: Turf war: Sheep vs forestry

Rather than vilifying forestry, Federated Farmers should focus on the facts.

Richard Holloway 06 Jun 2025
More means testing is inevitable
Opinion

Cameron Bagrie: More means testing is inevitable

More means testing is inevitable, and not just for NZ Super.

Cameron Bagrie 05 Jun 2025
KiwiSaver flows slow as retail funds track higher
Opinion

David Chaplin: KiwiSaver flows slow as retail funds track higher

Growth is a mix of investment performance and flows.

David Chaplin 04 Jun 2025